Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
- PMID: 29033411
- PMCID: PMC5820031
- DOI: 10.2169/internalmedicine.8550-16
Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
Abstract
Objective Little information is available on the relationship between the clinical course of ulcerative colitis (UC) and the outcomes of pregnancy and delivery in pregnant Japanese women. The aim of this retrospective study was to determine the factors that influence pregnancy and childbirth in middle-aged UC patients. Methods We studied 53 pregnancies in 45 pregnant women with UC who delivered at our department. They included 41 pregnancies that started while in UC remission and 12 pregnancies that started in the UC active phase. The following factors were evaluated: 1) the clinical course of UC; 2) the frequency and details of abnormal pregnancy/abnormal delivery; and 3) the course of pregnancy/delivery. We compared the clinical features, course of UC, and details of treatment between women with a normal pregnancy/delivery and those with an abnormal delivery. Results A comparison of the remission and acute groups showed lower clinical activity indices (CAIs) during pregnancy in the remission group and significantly higher rates of recurrence/exacerbation in the active group (75%) than in the remission group (7.3%). The respective CAIs in the first, second, and third trimesters were 3 and 6, 3 and 5, and 3 and 4, in the remission and active groups, respectively. Live infants were delivered in 51 (96%) pregnancies, with 7 (17%) abnormal pregnancies in the remission group and 4 (33.3%) in the active group (p>0.05). Abnormal delivery occurred in 16 of 53 (30.1%) pregnancies, and the rate was higher in the remission group than in the active group (p>0.05). In both groups, the most common abnormal event during pregnancy was delivery of low-birth-weight infants. Delivery was normal in 37 cases and abnormal in 16 cases. A multivariate analysis showed that a shorter UC disease duration (odds ratio=1.16) and higher CAI in the first trimester (odds ratio=1.49) were associated with an increased risk of abnormal pregnancy. Conclusion Our findings demonstrated that the clinical course of UC, as evaluated by the CAI, during pregnancy influenced the outcome of pregnancy and delivery.
Keywords: childbirth; clinical course [clinical activity index (CAI); Lichtiger index]; maintenance of remission; pregnancy; ulcerative colitis.
Figures
Similar articles
-
Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.Dig Dis Sci. 2017 Aug;62(8):2054-2062. doi: 10.1007/s10620-016-4353-5. Epub 2016 Oct 26. Dig Dis Sci. 2017. PMID: 27785711
-
[Inflammatory bowel disease and pregnancy: clinical study of mutual influence, clinical course and treatment].Nihon Shokakibyo Gakkai Zasshi. 1999 Mar;96(3):266-72. Nihon Shokakibyo Gakkai Zasshi. 1999. PMID: 10214074 Japanese.
-
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.Aliment Pharmacol Ther. 2013 Sep;38(5):501-12. doi: 10.1111/apt.12412. Epub 2013 Jul 15. Aliment Pharmacol Ther. 2013. PMID: 23855425
-
[Chronic idiopathic enterocolitis and pregnancy. Reciprocal repercussions and treatment].J Gynecol Obstet Biol Reprod (Paris). 1993;22(1):59-65. J Gynecol Obstet Biol Reprod (Paris). 1993. PMID: 8096531 Review. French.
-
[Ulcerative colitis and pregnancy].Nihon Rinsho. 1999 Nov;57(11):2603-7. Nihon Rinsho. 1999. PMID: 10572439 Review. Japanese.
Cited by
-
Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum.J Pharm Health Care Sci. 2022 Jul 1;8(1):18. doi: 10.1186/s40780-022-00249-8. J Pharm Health Care Sci. 2022. PMID: 35773736 Free PMC article.
-
Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid.BMC Gastroenterol. 2021 Jul 30;21(1):302. doi: 10.1186/s12876-021-01853-y. BMC Gastroenterol. 2021. PMID: 34330215 Free PMC article.
-
Ulcerative Colitis in Pregnancy: A Japanese Multicenter Cohort Study Focusing on Their Mutual Influence.Intern Med. 2025 Jun 1;64(11):1633-1639. doi: 10.2169/internalmedicine.4347-24. Epub 2024 Nov 8. Intern Med. 2025. PMID: 39522998 Free PMC article.
-
Rectovaginal Fistula From Untreated Ulcerative Colitis in Pregnancy: A Case Report and Review of the Literature.Cureus. 2023 Jun 19;15(6):e40662. doi: 10.7759/cureus.40662. eCollection 2023 Jun. Cureus. 2023. PMID: 37485139 Free PMC article.
References
-
- Suzuki Y. 2015 Report of a research project for action for specified intractable diseases supported by Health and Labour Sciences Research Grants “A study of refractory inflammatory bowel disease.”
-
- Lichtiger S, Present DH, Kornbluth A, et al. . Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841-1845, 1994. - PubMed
-
- Bortoli A, Pedersen N, Duricova D, et al. . Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther 38: 328, 2013. - PubMed
-
- van der Woude CJ, Ardizzone S, Bengtson MB, et al. ; European Crohn's and Colitis Organization The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 9: 107-124, 2015. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical